Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease

被引:0
|
作者
Younossi, Zobair [1 ]
Harrison, Stephen [2 ]
Newsome, Philip N. [3 ,4 ,5 ]
Chan, Wah-Kheong [6 ]
Yilmaz, Yusuf [7 ,8 ]
de Ledinghen, Victor [9 ]
Costentin, Charlotte [10 ]
Zheng, Ming-Hua [11 ]
Wong, Vincent Wai-Sun [12 ]
Elkhashab, Magdy [13 ]
Huss, Ryan [14 ]
Myers, Robert [14 ]
Foucquier, Julie [15 ]
Aymeric, Labourdette [15 ]
Destro, Marie [15 ]
Fournier, Celine [15 ]
Miette, Veronique [15 ]
Sandrin, Laurent [15 ]
Boursier, Jerome [16 ,17 ]
Sanyal, Arun [18 ,19 ]
机构
[1] Inova Hlth Syst, Inova Med, Falls Church, VA USA
[2] Univ Oxford, Radcliffe Dept Med, Oxford, England
[3] Birmingham Univ Hosp, Natl Inst Hlth Res Biomed Res Ctr, Birmingham, W Midlands, England
[4] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England
[5] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
[6] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia
[7] Marmara Univ, Inst Gastroenterol, Liver Res Unit, Istanbul, Turkey
[8] Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey
[9] Haut Leveque Hosp, Hepatol Gastroenterol & Digest Oncol, Pessac, France
[10] Grenoble Alpes Univ Hosp, Hepatol Gastroenterol & Digest Oncol, Grenoble, France
[11] Wenzhou Med Univ, Affiliated Hosp 1, NAFLD Res Ctr, Dept Hepatol, Wenzhou, Peoples R China
[12] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[13] Toronto Liver Ctr, Toronto, ON, Canada
[14] Gilead Sci, Forster City, CA USA
[15] Echosens, Paris, France
[16] Angers Univ Hosp, Hepatogastroenterol & Digest Oncol Dept, Angers, France
[17] Angers Univ Hosp, HIFIH UPRES EA3859 Lab, Angers, France
[18] VCU Hlth Syst, Richmond, VA USA
[19] NIDDK, NASH Clin Res Network, NIH, Bethesda, MD 26506 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OS-555
引用
收藏
页码:S257 / S257
页数:1
相关论文
共 50 条
  • [41] Development of a Noninvasive Fibrosis Score for Chinese Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Lee, Chi Ho
    Seto, Wai Kay
    Ieong, Kelly
    Lui, David T. W.
    Fong, Ho Yi
    Wan, Helen
    Chow, Wing Sun
    Woo, Yu Cho
    Yuen, Man Fung
    Lam, Karen S.
    DIABETES, 2020, 69
  • [42] The value of noninvasive scoring systems for the diagnosis of advanced fibrosis in Egyptian patients with nonalcoholic fatty liver disease
    Rokaya A. Mohamed
    Mona I. Nabih
    Mohamed B. ElShobaky
    Hany M. Khattab
    The Egyptian Journal of Internal Medicine, 2014, 26 (4) : 162 - 169
  • [43] Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
    Prasoppokakorn, Thaninee
    Chan, Wah-Kheong
    Wong, Vincent Wai-Sun
    Pitisuttithum, Panyavee
    Mahadeva, Sanjiv
    Mustapha, Nik Raihan Nik
    Wong, Grace Lai-Hung
    Leung, Howard Ho-Wai
    Sripongpun, Pimsiri
    Treeprasertsuk, Sombat
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (15) : 1563 - 1573
  • [44] Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
    Thaninee Prasoppokakorn
    Wah-Kheong Chan
    Vincent Wai-Sun Wong
    Panyavee Pitisuttithum
    Sanjiv Mahadeva
    Nik Raihan Nik Mustapha
    Grace Lai-Hung Wong
    Howard Ho-Wai Leung
    Pimsiri Sripongpun
    Sombat Treeprasertsuk
    World Journal of Gastroenterology, 2022, 28 (15) : 1563 - 1573
  • [45] The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort
    Cardoso, Ana Carolina
    Cravo, Claudia
    Calcado, Fernanda Luiza
    Rezende, Guilherme
    Campos, Carlos Frederico F.
    Neto, Joao Marcello A.
    Luz, Rodrigo P.
    Soares, Jorge Andre S.
    Moraes-Coelho, Henrique Sergio
    Leite, Nathalie C.
    Perez, Renata M.
    Villela-Nogueira, Cristiane A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (02) : 231 - 238
  • [46] Performance of the fibroscan and other noninvasive scales for detecting hepatic fibrosis in patients with nonalcoholic fatty liver disease
    Saez, E.
    Conde, I.
    Blazquez, T.
    Garcia-Morales, N.
    Perez, J.
    Tenias, J. M.
    Saiz, V.
    Zaragoza, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S156 - S156
  • [47] Role of fibroscan in diagnosis of fibrosis in non alcoholic fatty liver disease in indian patients
    Behl, N.
    Nijhawan, S.
    Bali, A.
    Mathur, A.
    Sharma, S. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 177 - 177
  • [48] Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
    Hayashi, Tatsuya
    Saitoh, Satoshi
    Fukuzawa, Kei
    Tsuji, Yoshinori
    Takahashi, Junji
    Kawamura, Yusuke
    Akuta, Norio
    Kobayashi, Masahiro
    Ikeda, Kenji
    Fujii, Takeshi
    Miyati, Tosiaki
    Kumada, Hiromitsu
    GUT AND LIVER, 2017, 11 (05) : 674 - 683
  • [49] VALIDATION OF NONINVASIVE FIBROSIS SCORES IN PREDIABETIC PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Phuc Le
    Yu, Pei-Chun
    Singh, Amandeep
    Chi Nguyen
    Singh, Tavankit
    McCullough, Arthur
    Rothberg, Michael
    GASTROENTEROLOGY, 2018, 154 (06) : S1169 - S1170
  • [50] Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
    Xu, Xiaotong
    Jin, Jinglan
    Liu, Yuwei
    ARAB JOURNAL OF GASTROENTEROLOGY, 2023, 24 (04) : 189 - 197